Searched for
CLARIS PHARMA
Baxter to acquire Claris Injectables for Rs 4,237 crore"The Boards of Directors of both companies have approved the proposed acquisition, which is expected to close in the second half of 2017," ...- Top PE firms join race for Claris Lifesciences’ US businessThe business is expected to be valued at over $500 million and may also attract interest from a Chinese drugmaker and some Indian pharma co...
- Claris Lifesciences revives talks to sell injectables businessSources suggest that it has evinced interest amongst pharma companies like Cadila Healthcare, Dr Reddy’s Labs, Torrent Pharma amongst other...
- Income-Tax Dept searches 20 premises of Claris LifesciencesIncome-Tax sleuths today conducted search and survey operations at around 20 commercial and residential premises of Claris Lifesciences, it...
- Carlyle Group sells its entire 11.29% stake in Claris LifesciencesCarlyle Group offloaded its entire 11.29 per cent stake in drug-maker Claris Lifesciences for a little over Rs 170 crore through an open ma...
- Claris transfers two businesses to Japan JV for Rs 1,050 crClaris will continue to hold a 20 per cent stake in the JV, while Otsuka and Mitsui will hold 60 and 20 per cent in it, respectively, a com...
- Claris promoter sells 12 lakh shares for over Rs 23 croreClaris Lifesciences promoter Aditya Sushil Kumar Handa today offloaded nearly 12 lakh shares of the pharma company for over Rs 23 crore.
- Claris Lifesciences inks JV with Japanese drug maker Otsuka Pharma & Mitsui for Indian marketAhmedabad-based Claris Lifesciences Limited, India executed agreements for a Joint Venture with two Japan-based drug makers Otsuka Pharmace...
- Claris Lifesciences in talks with Otsuka Pharma to sell injectables business: SourcesShares of Claris have rallied 165 per cent from the start of the year and are currently trading at their lifetime high.
- Mitsui in talks to invest Rs 250 crore in ClarisSources said the Japanese group's healthcare company might pick up stake from private equity players invested in Claris or invest in a join...
- Adani group, Claris Lifesciences stock prices fall sharplyStock prices of Adani group companies and Claris Lifesciences fell sharply on Monday when the benchmark BSE Sensex closed 104 points lower.
- Pfizer ends supply deal with Claris LifesciencesMultinational drug-maker Pfizer Inc has terminated its three-year old supply deal with Claris Lifesciences, immediately after a ban on the ...
- Claris Lifesciences to resume export to US post USFDA nodThe approval will allow Claris to manufacture and sell its products in te US and also receive abbreviated new drug application approvals, t...
- Claris Lifesciences yet to get USFDA clearanceClaris Lifesciences said its consolidated net profit rose 9% for the first quarter of calendar year 2012 to Rs 21.7 crore.
- Claris gets Russian nod for anti-infective drugsClaris raised Rs 300 crore in December through its maiden IPO. On Thursday, its stock dipped 2.48% to close at Rs 161.40.
- Claris gets nod for Rs 300-crore IPOClaris Lifesciences Ltd, has finally received approval from SEBI for its maiden public issue to raise Rs 300 crore.
- Pfizer ties up with Claris for injectablesWorld No 1 pharma company Pfizer on Wednesday announced a marketing tie-up with Rs 800-crore Ahmedabad-based Claris Lifesciences, that spec...
- Hospira-Mayne deal likely to alter pharma equations hereOne of the biggest trans-continent deals in the generic pharma sector is likely open the floodgates of opportunities for the Indian pharma ...
- Claris enters pact with Mayne, SandozContinuing with its overseas expansion plans, Ahmedabad-based pharmaceutical firm Claris Lifesciences today said it had entered into strate...
- Claris Lifesciences makes inroads into GermanyClaris Lifesciences, which recently attracted investment from leading international pharma group Carlyle, has formally made inroads into th...
Load More
